Company news
Vitasora Health Limited (ASX:VHL) news
Vitasora Health Limited news releases on 6ix. Latest, Feb 14, 2023: Successful close of Share Purchase Plan
Press releases — page 2
Successful close of Share Purchase Plan
February 13, 2023
RPM successfully reimbursed and claimed by physicians
February 5, 2023
Security Purchase Plan extension of closing date
January 24, 2023
Nth Carolina hospital commence wheezo RPM patient onboarding
January 8, 2023
Security Purchase Plan
December 27, 2022
Arkansas Heart Hospital commences patients on wheezo RPM
December 22, 2022
wheezo RPM program expands into New Mexico USA
December 15, 2022
First patients selected and enrolled into Minnesota Lung Ctr
December 13, 2022
First primary care practice secured and first patients
December 6, 2022
wheezo RPM program selected by leading USA heart center
November 27, 2022
Minnesota Lung Centre select wheezo and RMP for pilot prog.
November 17, 2022
Chairman and CEOs Presentation to Shareholders
November 14, 2022
Key milestone - First patients enrol into wheezo RPM program
November 6, 2022
Centre of Digital Innovation Excellence established
September 27, 2022
Placement of $1.6m to Support US Expansion
September 21, 2022
Investor USA market update and presentation
August 17, 2022
Monthly Activities/Appendix 4C Cash Flow Report
July 29, 2022
Wheezo successfully integrated in Michigan Children Hospital
July 28, 2022
Investor presentation
July 15, 2022
New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
July 11, 2022
Reinstatement to Quotation
May 2, 2022
Completion of Placement
May 2, 2022
RPM pilot program at Childrens Hospital of Michigan
March 14, 2022
Second RPM Agreement with Access TeleHealth
February 6, 2022
Respiri secures a second order from mTeleHealth
February 3, 2022
Respiri enters Distribution/Marketing Agreement in USA
December 22, 2021
Clarification Announcement
July 4, 2021
Webinar presentation - Investor Update
June 23, 2021
Pharmacy Network to Commence Sales of wheezo
June 22, 2021
Trading Update
June 14, 2021
Appendix 4C - quarterly
April 29, 2021
Respiri Partnership with TerryWhite Chemmart Group
April 27, 2021
Investor Presentation
March 22, 2021
Half Year Accounts
February 19, 2021
Company Update Post Commercial Launch
December 8, 2020
Manufacturing update
November 3, 2020
Cleansing Prospectus
October 19, 2020
Entech Electronics appointed as Global Manufacturing Partner
September 21, 2020
Positive wheezo clinical study results
August 31, 2020
Product Referral Agreement executed with Aust Patients Assoc
August 19, 2020
CY21 Revenue Guidance
July 26, 2020
Respiri signs with BNPL provider ZIP - update
July 20, 2020
Respiri signs with BNPL provider ZIP
July 19, 2020
Exclusive International Sales Agreement with Cipla
July 16, 2020
Agreement with UK Data Research Centre executed
June 25, 2020
Settlement with former CEO
June 18, 2020
Service Agreement with Pharmacy Guild of Australia
June 16, 2020
CEOs Address to Shareholders
May 26, 2020
Security Purchase Plan - Completed
May 5, 2020
Joint Development Agreement signed with Phenix Health
April 14, 2020